Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 6
Submit an article Journal homepage
337
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual disease

Urszula SobolLoyola University Medical Center, Maywood, IL, USACorrespondence[email protected]
,
Tulio RodriguezLoyola University Medical Center, Maywood, IL, USA
,
Scott SmithLoyola University Medical Center, Maywood, IL, USA
,
Aileen GoLoyola University Medical Center, Maywood, IL, USA
,
Ross VimrLoyola University Medical Center, Maywood, IL, USA
,
Mala ParthasarathyLoyola University Medical Center, Maywood, IL, USA
,
Rong GuoLoyola University Medical Center, Maywood, IL, USA
&
Patrick StiffLoyola University Medical Center, Maywood, IL, USA
 show all
Pages 1281-1287 | Received 25 Jun 2013, Accepted 19 Aug 2013, Published online: 03 Oct 2013

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Philip A. Thompson, Travis Perera, David Marin, Betul Oran, Uday Popat, Muzaffar Qazilbash, Nina Shah, Simrit Parmar, Katayoun Rezvani, Amanda Olson, Partow Kebriaei, Paolo Anderlini, Gabriela Rondon, Amin Alousi, Stefan Ciurea, Richard E. Champlin, Ashish Bajel, Jeffrey Szer, Elizabeth J. Shpall, David Ritchie & Chitra M. Hosing. (2016) Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma. Leukemia & Lymphoma 57:7, pages 1607-1615.
Read now
Tim Illidge, Reda Bouabdallah, Robert Chen, Ajay K. Gopal, Craig H. Moskowitz, Radhakrishnan Ramchandren, Andrei R. Shustov, Herve Tilly, Tanya M. Trippett, Adam Gibb, Laurie E. Grove & Ranjana Advani. (2015) Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Leukemia & Lymphoma 56:3, pages 703-710.
Read now
Andrew B. M. Lim & David S. Ritchie. (2014) Hodgkin lymphoma, allogeneic transplant and the graft-versus-tumor effect: size does matter. Leukemia & Lymphoma 55:6, pages 1223-1224.
Read now

Articles from other publishers (6)

Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, Rui Li, Ying Huang, Abdullah Khan, David Bond, Yazeed Sawalha, John Reneau, Lapo Alinari, Robert Baiocchi, Beth Christian, Kami Maddocks, Yvonne Efebera, Sam Penza, Ayman Saad, Jonathan Brammer, Marcos DeLima, Samantha Jaglowski & Narendranath Epperla. (2023) Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents. Cancer Medicine 12:7, pages 8228-8237.
Crossref
A Rashidi, M Ebadi & A F Cashen. (2016) Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis. Bone Marrow Transplantation 51:4, pages 521-528.
Crossref
U Sobol, A Go, S Kliethermes, S Bufalino, T Rodriguez, S Smith, M Parthasarathy & P Stiff. (2015) A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplantation 50:12, pages 1519-1525.
Crossref
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, Linda J. Burns, Robert Chen, Peter D. Cole, Andrew M. Evens, Ginna G. Laport, Craig H. Moskowitz, Uday Popat, Nishitha M. Reddy, Thomas C. Shea, Julie M. Vose, Jeffrey Schriber, Bipin N. Savani & Paul A. Carpenter. (2015) Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 21:6, pages 971-983.
Crossref
Ajay K. GopalRobert ChenScott E. SmithStephen M. AnsellJoseph D. RosenblattKerry J. SavageJoseph M. ConnorsAndreas EngertEmily K. LarsenXuedong Chi, Eric L. SieversAnas Younes. (2015) Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. Blood 125:8, pages 1236-1243.
Crossref
Francesca Montanari & Catherine Diefenbach. (2014) Relapsed Hodgkin Lymphoma: Management Strategies. Current Hematologic Malignancy Reports 9:3, pages 284-293.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.